Merck licenses experimental HIV pill to generic makers in 129 countries - Reuters
Merck licenses experimental HIV pill to generic makers in 129 countries Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPU1ZweHFqeWNzNV96d3M5OTQtREpWR1FVSk1vRGltYWMtdkowSG1Ib2UwME5xN3lhcXVYNU9WZExCQThzUDRYbE52Tno1b21xd29mVGp6ZmMycERVX2V4T3NtM0kxd0pXdWxoTVlteHNhVzlqUENBcVlMN0VlR1FQYXZvemJQY1U5MzMzTktFM1UzRGd0WldJdVNHZjlpQ3hxb21LdzY1Z3d6R2RJSVU1QjlRSnZxeE1xMXc?oc=5" target="_blank">Merck licenses experimental HIV pill to generic makers in 129 countries</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novo Nordisk to license experimental GLP-1 pill from China's Hengrui - Reuters
Novo Nordisk to license experimental GLP-1 pill from China's Hengrui Reuters
September 29, 2026 at 04:47 AMUS FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMMerck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters
September 28, 2026 at 04:14 PMLilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com
Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com
September 29, 2026 at 10:15 PMAbbVie joins US government pilot to test drug discount rebates - Reuters
AbbVie joins US government pilot to test drug discount rebates Reuters
October 2, 2026 at 08:53 PMAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AM